Invention Grant
- Patent Title: Amphoteric liposome formulation
- Patent Title (中): 两性脂质体制剂
-
Application No.: US12085893Application Date: 2006-12-01
-
Publication No.: US08367628B2Publication Date: 2013-02-05
- Inventor: Neal Clifford Goodwin , Gerold Endert , Natalie Herzog , Yvonne Kerwitz , Steffen Panzner , Wendi Rodrigueza
- Applicant: Neal Clifford Goodwin , Gerold Endert , Natalie Herzog , Yvonne Kerwitz , Steffen Panzner , Wendi Rodrigueza
- Applicant Address: US MI Kalamazoo DE Halle
- Assignee: ProNAi Therapeutics, Inc.,Novosom AG
- Current Assignee: ProNAi Therapeutics, Inc.,Novosom AG
- Current Assignee Address: US MI Kalamazoo DE Halle
- Agency: Honigman Miller Schwartz and Cohn LLP
- Agent Jonathan P. O'Brien; Kelly T. Murphy
- International Application: PCT/US2006/045955 WO 20061201
- International Announcement: WO2007/064857 WO 20070607
- Main IPC: C12N15/11
- IPC: C12N15/11 ; C07H21/02 ; C07H21/04 ; C12Q1/68
Abstract:
The invention relates to compositions and methods to inhibit gene expression. In particular, the invention provides DNAi oligonucleotides sequestered by amphoteric liposomes for the treatment of cancer.
Public/Granted literature
- US20090220584A1 Amphoteric Liposome Formulation Public/Granted day:2009-09-03
Information query
IPC分类:
